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The stagnation of biomedical research funding in the US is placing great pressure on the 
research enterprise. It is time to consider some radical solutions.For decades, the United States has 
been the unchallenged world leader 
in biomedical research. Spending by 
the US on scientific research is the 
highest in the world, winners of major 
biomedical research prizes such as 
the Nobel and Lasker have largely 
been drawn from scientists working 
in the US, research output as judged 
by publications, scientific advances, 
and innovative biotechnological and 
clinical applications is high, and the US 
has long been a magnet for the best 
research talent from around the world. 
This leading position has meant that 
US biomedical scientists have always 
expressed great confidence in their 
country’s research enterprise. So as 
a newcomer to American science, it is 
a surprise for me to see the slippage 
in confidence that has occurred dur-
ing the last couple of years. Worries 
and anxieties abound. Barely a day 
goes by without a scientist expressing 
concern over issues such as levels of 
funding, recruitment of researchers, 
restrictions on research projects, and 
potential political interference in scien-
tific judgments. Is biomedical research 
in the US under siege and, if so, what 
can be done about it?
Nothing saps morale more than 
anxieties over research funding. After 
the dramatic rise in support for the 
National Institutes of Health (NIH), 
which has led to a doubling in research 
funds from 1998 to 2003, increases 
in the last 3 years have struggled to 
keep pace with inflation. The outlook 
is worsening, with many expecting the 
overall budget to increase less than 
inflation, leading to a decline in the real 
size of individual research grants. The 
success rate of awards compared with 
applications has slipped from close to 
one in three in the late 1990s to nearly one in five. When many applications 
are of a high quality, low success rates 
increase to an undesirable level the 
influence of chance in decision mak-
ing. This is bad for the overall research 
enterprise and is demotivating for the 
investigators making applications.
The increased pressure on NIH 
resources focuses attention on the 
mechanisms by which research sup-
port allocations are made. The appli-
cation process is very time consuming 
and is generally considered to be risk 
averse. The documentation required 
for an average research project grant 
application of $250,000 per year is 
25 pages in length, and sometimes 
further rewrites are requested by the 
evaluating study section commit-
tee before a final decision is made. 
The level of detail needed for these 
grants is very considerable, and this, 
together with the low success rate, 
puts significant demands on the com-
mittee members who decide which 
grants should be funded. The present 
situation also encourages conserva-
tism both in applicants and asses-
sors. Innovative applications tend not 
to be supported because they are 
considered too risky, and the general 
strategy used by most applicants is 
to propose projects that are already 
largely completed because these will 
be less vulnerable to criticism.
This stagnation in research funding 
is placing great pressure on the US 
biomedical research enterprise. There 
is a pressing need to re-examine the 
overall Federal budget so that at the 
very least the present budget level is 
preserved. A compelling case for yet 
further expansion has been made in 
a recent report from the US National 
Academies of Sciences and Engi-
neering and the Institute of Medicine; Cell 124the report recommends an increase 
in science research funding of 10% 
per year for the next 7 years. Equally 
important as increasing the overall 
budget is a more thoughtful analysis 
of the impact of budgetary changes. 
Rapid expansion followed by stagna-
tion is particularly damaging given 
the age structure of research groups. 
Biomedical research groups are com-
posed largely of young scientists in 
training, most often students and 
postdoctoral researchers, nearly all of 
whom will be under 35 years of age. 
This age structure is inherently unsta-
ble because although many young 
scientists are being trained, there 
are relatively few principal investiga-
tor group leader positions available 
for them later in their careers. When 
budgets expand, more students and 
postdoctoral scientists are required to 
drive the engine of research, and uni-
versities and institutes construct larger 
research facilities to take advantage 
of the increased funds and indirect 
costs that become available. Several 
years after such a budget expan-
sion, there will be a further increase 
in the numbers of trainees searching 
for independent principal investigator 
positions. If at the same time funding 
stagnates, then an already difficult 
problem becomes almost impossible 
to manage. This is what is happening 
with the present budget trajectory for 
NIH. Much more attention needs to 
be paid to the effects of such stop-
go funding. Present policies are set to 
damage a whole generation of young 
research workers, and the negative 
impact on recruitment of the next gen-
eration of research scientists will be 
seen for years to come.
More radical solutions to this 
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Research groups could be smaller, 
potentially allowing principal investiga-
tors to continue as active experimen-
talists for more of their career rather 
than being diverted at an early stage 
into constant grant writing. Smaller 
research groups could come together 
into larger groupings for particular 
projects, with these groupings form-
ing and dissolving as the science 
demands. Such a structure could 
also encourage more interdisciplinary 
research. These cultural changes 
would result in more independent prin-
cipal investigator positions, improving 
the overall career structure for research 
workers. Similarly, the mechanisms by 
which research support allocations 
are made need to be overhauled. The 
grant funding processes followed by 
government agencies in other coun-
tries and by some non-Federal private 
funding agencies are less lengthy and 
time consuming than that used by the 
NIH. Shorter, less-detailed applications 
can be sufficient for effective decision 
making if well structured and could 
encourage less conservative applica-
tions. One of the very best guides to 
future achievement is past accom-
plishment, and so for many estab-
lished researchers, greater emphasis 
could be given to assessing what they 
have accomplished in the recent past. 
Such an approach simplifies assess-
ment and shifts the emphasis from 
future research project appraisals, 
which are subjective and difficult to 
judge, toward the capability of the indi-
vidual researcher where criteria can be 
more objective. Such an ad hominem 
approach has been used very effec-
tively by one of the most successful 
of the US biomedical research organi-
zations, the Howard Hughes Medical 
Institute. Of course, not all researchers 
are at a career stage when they can 
be judged by past achievement, and 
assessment in their cases will require 
greater attention to their proposed 
future projects. Younger research-
ers starting their careers and those 
applying for research support after a 
less productive period would fall in this 
category. Even so, the overall work 
load for applicants and assessors as 
well as the quality of decision making 
would be considerably improved by 10 Cell 124, January 13, 2006 ©2006 Elsevmore emphasis on past achievement. 
The use of ad hominem approaches 
could also be expanded for postdoc-
toral researchers of high quality. If they, 
rather than the principal investigator, 
were awarded the funds to support 
their salary and research and if they 
had greater freedom to later change 
the research group in which they work, 
then postdoctoral mentoring might 
also be improved. However, politicians 
may resist putting more emphasis on 
ad hominem and past performance 
criteria for research grant assessment. 
Politicians have seldom been directly 
exposed to the research process 
and do not always understand how 
it works. They are likely to feel that 
specific research projects should be 
identified and supported and will be 
uncomfortable with the idea of putting 
more emphasis on supporting a tal-
ented individual rather than a project 
because it will seem that they are not 
taking their public responsibilities seri-
ously. Politicians would benefit from 
better guidance on how to assess sci-
entific research more effectively.
A second major issue sapping the 
confidence of US biomedical research-
ers is the increasing opinion that the 
present political leadership and certain 
influential parts of US society appear to 
have little understanding of, or respect 
for, science. For many decades, the 
US has had a reputation for respect-
ing the pursuit of knowledge and for 
recognizing that science forms the 
basis for commercial innovation, tech-
nological advances, better health, and 
improvements in the quality of life and 
the environment. Many would argue 
that the pre-eminent commercial 
strength of the US is directly related 
to the strength of its scientific base. 
However, scientists are now beginning 
to wonder whether the present politi-
cal climate is still sympathetic to this 
approach.
Two scientific issues illustrate these 
concerns: the debate over Darwin-
ism and Creationism and research 
on human embryonic stem cells. The 
attack on Darwinism by supporters of 
Intelligent Design is a straightforward 
attack on science itself. Intelligent 
Design is not science because it pro-
poses a supernatural designer as an ier Inc.explanation for evolutionary change. It 
is quite extraordinary that the Scopes 
trial of the 1920s is once again being 
revisited in parts of the US where 
attempts are being made to replace 
scientific teaching in schools with 
explanations based on religious beliefs. 
President Bush commented on this 
issue when a group of Texas newspa-
per reporters asked whether Intelligent 
Design should be taught alongside 
evolution as competing theories. His 
response was, “Both sides ought to be 
properly taught…so people can under-
stand what the debate is about.” This 
unfortunate reply allowed Creationists 
to claim that the US political leadership 
supported their antiscientific views, 
and tellingly these claims brought no 
response from the President to clarify 
the matter. Even senior leaders of US 
biomedical science seem to be rather 
nervous about taking a stand over 
the Creationism issue. When the NIH 
Director, Dr. Elias Zerhouni, was asked 
by Science magazine whether he was 
personally concerned about the Intel-
ligent Design movement taking off in 
schools, he said, “I am very concerned 
about it. And I don’t think it’s a good 
direction.” But in the same interview 
when asked why NIH had not been 
very visible in the debate over Intelli-
gent Design, his response was “Why 
should it? Why do you think NIH should 
be visible in that debate?” One answer 
is that if human pathogens are being 
intelligently designed in response to 
the evolutionary pressures brought 
about by prolonged exposure to anti-
biotics, changes will be required in the 
current NIH strategies used to combat 
infectious diseases. Dr. Zerhouni has a 
difficult job spanning the political and 
scientific worlds, but it is crucial that 
great US scientific institutions like the 
NIH are unequivocal in their defense 
of science, especially over an issue 
that is as fundamental to biomedicine 
as Darwinism. This is a very important 
matter because the failure of the lead-
ership to robustly support science will 
eventually be damaging for the whole 
scientific enterprise in the US.
The debate over human embryonic 
stem cells is more complex but also 
has consequences beyond the imme-
diate issue of defining the types of 
experiments that are permissible. It is 
complex because it embraces difficult 
ethical questions such as when does 
life begin and the appropriateness of 
taking what some see as an overly 
utilitarian approach to the early human 
embryo. What has been lacking is a 
reasoned dialog among society, politi-
cians, and scientists to debate these 
issues, and this failure has led to poor 
legislation. Present NIH guidelines 
allow federal support only for the so-
called Presidential human embryonic 
stem cell lines made prior to August 
2001. Any research using stem cell 
lines made after this arbitrary date 
cannot be funded by federal money, 
and indeed any investigator or insti-
tution making or using such cell lines 
with federal support could be severely 
punished.
This limitation made little sense to 
many people when initially drafted, 
given that the early human embryos 
used for stem cell derivation were 
obtained from fertility clinics and were 
in excess of clinical requirements. It 
makes less sense now given that only 
a small handful of the Presidential 
stem cell lines remain viable and use-
ful for research and, in any case, none 
of these lines can be used for clinical 
applications. What further underscores 
the inconsistency of this approach is 
the fact that human embryonic stem 
cell lines can still be made and experi-
mented with if such work is privately 
funded, indicating that the political 
leadership does not consider that US 
society as a whole thinks that it is mor-
ally repugnant because, if it did so, 
such work should have been banned 
regardless of the funding source. A 
further significant consequence of the 
present arrangements is that scientists 
and their host institutions pursuing 
human embryonic stem cell work have 
been placed in a deeply uncomfortable, 
almost intolerable situation. The quar-
antine measures demanded by NIH to 
keep private and federal funding totally 
separate raise the extraordinary possi-
bility that, should one eppendorf tube 
bought with NIH funds be used acci-
dentally in human embryonic stem cell 
research, all the NIH funds awarded to 
that institution might be at risk. Even 
more disturbing is that, in this atmos-phere of fear, strangely reminiscent of 
Galileo being shown the instruments 
of torture because of his heliocentric 
views, the scientific community may 
begin to lose its confidence and start 
to turn on itself. Scientists receiving 
federal funding in areas related to stem 
cell work may start to criticize their 
colleagues who they think are “rock-
ing the boat.” Confidential peer review 
of publications and grants will be at 
risk of becoming increasingly more 
conservative as individual scientists 
become concerned that federal sup-
port for their own work may be put in 
jeopardy if too much attention is drawn 
to the human embryonic stem cell field 
by work that may be seen to be contro-
versial. Such self-censorship becomes 
a threat to academic freedom. Scien-
tists need courage to prevent such 
developments and to ensure that their 
colleagues carrying out human embry-
onic stem cell research are adequately 
defended by the scientific community. 
The whole issue of stem cells reflects 
the pressing need for more debate 
and better dialog with the public about 
scientific issues.
A further concern for biomedical 
researchers is recruitment. An unfor-
tunate consequence of the terrible 
September 11, 2001 attack on New 
York City has been increased visa and 
immigration restrictions combined 
with a mounting sense of “Fortress 
America” increasingly trying to insulate 
itself from the rest of the world. The 
numbers of overseas students com-
ing to the US has significantly dropped 
since 2001, and stories of increased 
bureaucracy and long delays in visa 
processing are common. This shift is 
alien to the well-established US tradi-
tion of encouraging the immigration 
of talented individuals and visiting 
scholars from overseas. The stimu-
lating and invigorating “melting-pot” 
conditions that prosper when differ-
ent cultures and traditions meet and 
interact are extremely important for 
scientific research. High-quality inno-
vative science and, for that matter, 
thriving industry and trade prosper in 
interactive and outgoing societies as 
seen during the Golden Age of seven-
teenth century Holland, Victorian times 
in nineteenth century England, and the Cell 124, twentieth century in the US. The prob-
lem is made more acute because the 
US fails to generate enough home-
grown scientists to drive the scientific 
endeavor. Despite heroic efforts from 
the US National Academy of Sciences 
to improve science teaching in schools, 
insufficient numbers of students are 
taking up science, and this shortfall 
can be made up only by students and 
scholars coming from overseas.
Crucial to dealing with these prob-
lems is the need to persuade America’s 
political leaders that they must take 
science more seriously. Politicians will 
only do that if they judge that society 
more generally believes that science 
really matters. Science is important to 
society because it is essential both for 
achieving a better quality of life and for 
sustaining an effective democracy in 
an increasingly technological age. Two 
of the factors that can help to raise the 
profile of science in society are bet-
ter science education in schools and 
improved dialog with the public over 
scientific issues.
Teaching science well in schools is 
difficult, and for many years it has been 
recognized that science education in 
US schools needs to be improved. 
Good science teaching will enable 
adult citizens to participate more effec-
tively in political decisions involving sci-
ence, and more people will be drawn 
to working in the scientific endeavor. 
The characteristic features of science 
need to be communicated to students 
in schools; these include respect for 
objective evidence and observation, 
reliance on rational argument, encour-
agement of skepticism, the need for 
consistency, and providing the most 
reliable understanding of the natural 
world. The fact that scientific explana-
tions at the boundaries of knowledge 
are often tentative also needs to be 
emphasized at school so that later in 
life, citizens will better appreciate the 
complex issues that arise when sci-
ence meets politics. Most importantly, 
schools must resist those who delib-
erately confuse religion with science 
in their attempts to impose their own 
religious beliefs on the classroom in 
the guise of science. Today, Creation-
ists promoting Intelligent Design as 
science are leading that antiscience January 13, 2006 ©2006 Elsevier Inc. 11
lobby, and this movement must be 
vigorously opposed.
Better dialog with the public about 
science and issues raised by science 
is fundamental for a good relationship 
between science and society. In recent 
years, the communication of science 
to the public has much improved with 
many excellent popular books and 
mass media programs about science. 
But this communication has usually 
been only one way, from the scientist 
to the public, which does not reflect a 
true dialog. Scientists need to listen 
to the public as well, because that is 
the only way that we can really find 
out what scientific issues matter to the 
average person and what they think 
about those issues. Scientists should 
become more engaged at this grass 
roots level, not just with the intellectual 
elites, but with all parts of society in all 
parts of the country. This dialog should 
be open, responsive, and courteous, 
rejecting the polarized debates pro-
moted by the media; the discussion 
of scientific issues is not well suited 12 Cell 124, January 13, 2006 ©2006 Elseto a combative and confrontational 
approach. To help advance such 
dialog, scientists could volunteer to 
promote discussions in schools and 
should prevail upon national science 
societies to organize dialog meetings 
with the general public. If the public 
becomes more concerned with sci-
ence, then the political leadership will 
take science more seriously. Scien-
tists need to earn the trust and confi-
dence of the public if we are to retain 
our “license to operate.” But to do that 
we have to be accurate about what 
science can do. It is no good exag-
gerating what science can deliver, as 
happened when the Director of the 
National Cancer Institute, Dr. Andrew 
von Eschenbach, announced the Insti-
tute’s challenge goal in 2003 as “To 
eliminate the suffering and death due 
to cancer by 2015.” This cannot be 
justified even as a statement of aspira-
tion because when we fail to deliver, as 
we surely will with such a claim, we will 
lose the confidence and trust of both 
the politicians and the public.vier Inc.Biomedical research is still very 
strong in the US but is under siege. 
Unless this trend is corrected, science 
will be damaged by both stagnation 
in research funding and the failure of 
the political leadership to take sci-
ence seriously. These are unfortunate 
developments, given that the founding 
principles of the Republic forged at the 
height of the Enlightenment are imbued 
with a respect for openness, rational-
ism, and decisions based on objec-
tive evidence and observation. These 
same values are core to the scientific 
endeavor, and we scientists have a 
responsibility to engage with politi-
cians and society in the US to ensure 
both the continued pursuit of scientific 
knowledge and the use of that know-
ledge for the benefit of humanity.
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